학술논문
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC
Document Type
Article
Author
Tomita, Yoshihiko; Naito, Sei; Sassa, Naoto; Takahashi, Atsushi; Kondo, Tsunenori; Koie, Takuya; Obara, Wataru; Kobayashi, Yasuyuki; Teishima, Jun; Takahashi, Masayuki; Matsuyama, Hideyasu; Ueda, Takeshi; Yamaguchi, Kenya; Kishida, Takeshi; Shiroki, Ryoichi; Saika, Takashi; Shinohara, Nobuo; Oya, Mototsugu; Kanayama, Hiro-omi
Source
In Clinical Genitourinary Cancer August 2020 18(4):e374-e385
Subject
Language
ISSN
1558-7673